We are live on ! Find out more
ETC

Exchange Traded Concepts Portfolio holdings

AUM $21.9B
1-Year Est. Return 68.6%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
AUM
$4.06B
AUM Growth
+$411M
Cap. Flow
+$205M
Cap. Flow %
5.05%
Top 10 Hldgs %
21.64%
Holding
1,420
New
288
Increased
397
Reduced
560
Closed
115

Sector Composition

Rank Sector Weight
1 Technology 20.96%
2 Energy 10.24%
3 Healthcare 10.11%
4 Industrials 5.84%
5 Consumer Discretionary 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
826
Bank of America
BAC
$439B
$162K ﹤0.01%
5,656
+392
+7% +$11.2K
WEX icon
827
WEX
WEX
$6.23B
$162K ﹤0.01%
+890
New +$158K
AMAM
828
DELISTED
Ambrx Biopharma Inc
AMAM
$162K ﹤0.01%
+9,830
New +$124K
MCHB
829
Mechanics Bancorp
MCHB
$3.51B
$160K ﹤0.01%
27,052
ZNTL icon
830
Zentalis Pharmaceuticals
ZNTL
$329M
$159K ﹤0.01%
+5,654
New +$136K
ALLE icon
831
Allegion
ALLE
$13.7B
$159K ﹤0.01%
1,325
-235
-15% -$25.7K
CABO icon
832
Cable One
CABO
$249M
$156K ﹤0.01%
237
+3
+1% +$2.02K
BPMC
833
DELISTED
Blueprint Medicines
BPMC
$154K ﹤0.01%
+2,438
New +$133K
PAGS icon
834
PagSeguro Digital
PAGS
$2.69B
$153K ﹤0.01%
16,198
+1,251
+8% +$12.7K
ARW icon
835
Arrow Electronics
ARW
$10.8B
$152K ﹤0.01%
1,064
-57
-5% -$7.09K
ACRV icon
836
Acrivon Therapeutics
ACRV
$65.9M
$152K ﹤0.01%
+11,709
New +$142K
ERIE icon
837
Erie Indemnity
ERIE
$12.7B
$152K ﹤0.01%
+722
New +$161K
RLAY icon
838
Relay Therapeutics
RLAY
$3.99B
$152K ﹤0.01%
+12,067
New +$150K
TYRA icon
839
Tyra Biosciences
TYRA
$1.84B
$151K ﹤0.01%
+8,867
New +$129K
SNDX icon
840
Syndax Pharmaceuticals
SNDX
$1.74B
$151K ﹤0.01%
7,213
+6,355
+741% +$132K
IMRX icon
841
Immuneering
IMRX
$274M
$151K ﹤0.01%
+14,884
New +$143K
CHRW icon
842
C.H. Robinson
CHRW
$20B
$150K ﹤0.01%
1,595
-344
-18% -$33.3K
IMGN
843
DELISTED
Immunogen Inc
IMGN
$150K ﹤0.01%
+7,945
New +$93.8K
RVMD icon
844
Revolution Medicines
RVMD
$39.1B
$149K ﹤0.01%
+5,557
New +$136K
IMCR icon
845
Immunocore
IMCR
$1.7B
$148K ﹤0.01%
+2,476
New +$141K
DLB icon
846
Dolby
DLB
$4.97B
$148K ﹤0.01%
1,773
+490
+38% +$41K
ALSN icon
847
Allison Transmission
ALSN
$10B
$148K ﹤0.01%
+2,622
New +$129K
GNLX icon
848
Genelux
GNLX
$131M
$145K ﹤0.01%
+4,442
New +$125K
MOR
849
DELISTED
MorphoSys AG American Depositary Shares
MOR
$144K ﹤0.01%
+19,287
New +$117K
GLUE icon
850
Monte Rosa Therapeutics
GLUE
$1.86B
$144K ﹤0.01%
+20,996
New +$136K

Similar funds

Exchange Traded Concepts's Q2 2023 Portfolio in Review

As of Q2 2023, Exchange Traded Concepts held 1,420 positions worth $4.06B, up 11% from $3.65B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Exchange Traded Concepts deployed $205M of net new capital in Q2 2023, opening 288 new positions and adding to 397 existing holdings. Its largest new stake was Vanguard Long-Term Bond ETF: 2,114,708 shares worth $158M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was iShares 0-3 Month Treasury Bond ETF, an estimated $730M trimmed.

  • Exchange Traded Concepts's largest Q2 2023 buy was Vanguard Long-Term Bond ETF: 2,114,708 shares worth $158M.
  • Exchange Traded Concepts added most to Vanguard Long-Term Treasury ETF in Q2 2023, an estimated $69.8M increase.
  • Exchange Traded Concepts's biggest Q2 2023 reduction was iShares 0-3 Month Treasury Bond ETF, cutting an estimated $730M.
  • Exchange Traded Concepts fully exited Goldman Sachs Access Treasury 0-1 Year ETF in Q2 2023, selling an estimated $487M.
  • Exchange Traded Concepts's ten largest holdings make up 22% of its $4.06B portfolio in Q2 2023.
  • Exchange Traded Concepts opened 288 new positions and closed 115 in Q2 2023.
  • Exchange Traded Concepts's portfolio value rose 11% quarter-over-quarter to $4.06B.

Based on Exchange Traded Concepts's 13F filing for Q2 2023, filed 20 Jul 2023.